Status:
UNKNOWN
VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Collaborating Sponsors:
Guy's and St Thomas' NHS Foundation Trust
Liverpool University Hospitals NHS Foundation Trust
Conditions:
Ulcerative Colitis
Crohn's Disease
Eligibility:
All Genders
18+ years
Brief Summary
Vedolizumab has been approved for the treatment of both ulcerative colitis and Crohn's disease. The aim of this study is to capture the early real life UK experience of vedolizumab including the outco...
Eligibility Criteria
Inclusion
- Participants being given vedolizumab as part of routine care, and vedo naïve prior to study
- Age 18 or over
- Written informed consent obtained from patient for participation in the UK IBD Registry
Exclusion
- Patient unwilling to take part in the UK IBD Registry
- Unable to obtain written informed consent
- Patient is, in the opinion of the investigator, not suitable to participate in the study
- Patients with contraindications to the use of vedolizumab
Key Trial Info
Start Date :
February 3 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT03257345
Start Date
February 3 2017
End Date
December 31 2019
Last Update
September 21 2018
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Cornwall Hospitals NHS Trust
Truro, Cornwall, United Kingdom, TR1 3LJ
2
Royal Devon and Exeter NHS Foundation Trust
Exeter, Devon, United Kingdom, EX2 5DW
3
Brighton and Sussex University Hospitals NHS Trust
Brighton, East Sussex, United Kingdom, BN2 5BE
4
Kingston Hospital NHS Foundation Trust
Kingston, Greater London, United Kingdom, KT2 7QB